|Articles|January 9, 2020
PPD Expanding Clinical Development and Lab Capabilities in China
Advertisement
PPD, Inc.has expanded its operations and leadership team in China. This expansion of the company is to provide enhanced clinical development, laboratory, regulatory, site conduct, patient access and post-approval services for international and China-based biopharmaceutical companies.
To learn more, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Utilizing Tech Tools to Accelerate Drug Development
3
Inside the Recruitment Bottlenecks Driving Trial Delays
4
ACT Brief: Tech-Driven Data Strategies and Long-Term Vaccine Success
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
